September 10 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said that its sales revenue fell by an annual 4% in the first eight months of the year following a decrease in sales both on the domestic market and abroad.
Sopharma's exports declined 3% year-on-year in the January-August period, while sales in the country decreased 5% on the year, the drug maker said in a bourse filing last week.
In August alone, Sopharma's sales revenue increased 11% year-on-year. Exports grew 25% on the year in August, while domestic sales fell by 7%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 8:30 CET on Monday, Sopharma shares traded 0.74% higher at 4.1 levs ($2.42/2.10 euro) on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)